Deloitte appoints Robert Hillard as Asia Pacific Chief Executive Officer HONG KONG, June 1, 2026 /PRNewswire/ — Deloitte Asia Pacific today announced… CISION PRNewswireJune 1, 2026
Press Release Tech UOB and FPT sign MoU to advance AI, technology transformation and financial innovation opportunities SINGAPORE, June 1, 2026 /PRNewswire/ — UOB and global technology corporation FPT have… CISION PRNewswireJune 1, 2026
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept First-line NSCLC – Compelling Activity Across All PD-L1 SubgroupsIn first-line non-small cell… CISION PRNewswireJune 1, 2026
Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting SHANGHAI, June 1, 2026 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code:… CISION PRNewswireJune 1, 2026
Business Press Release MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026 TAIPEI, June 1, 2026 /PRNewswire/ — MICROIP (TPEx: 7796), specializing in AI… CISION PRNewswireJune 1, 2026
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview TAIPEI, June 1, 2026 /PRNewswire/ — Jyong Biotech Ltd. (Nasdaq: MENS) (the… CISION PRNewswireJune 1, 2026
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC Elisrasib monotherapy delivers an ORR of 78.0% and median PFS of 12.4… CISION PRNewswireJune 1, 2026
Press Release ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO SUZHOU, China, June 1, 2026 /PRNewswire/ — ImmVira Group ("ImmVira") today announced… CISION PRNewswireJune 1, 2026
